Rocklatan for extra pressure reduction after glaucoma surgery
Part of Eyes & vision clinical trials.
This trial tests if adding Rocklatan eye drops can lower eye pressure more in people who already had cataract surgery with a Hydrus microstent for glaucoma. It may help those who still need better pressure control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years or older
- You have mild to moderate open-angle glaucoma
- You had cataract surgery with a Hydrus microstent placed more than 3 months ago and within the last 2 years
- You are using 0 to 2 glaucoma eye drops and can safely stop them temporarily for the study
- Your untreated eye pressure is between 16 and 26 mmHg
- You have no history of severe glaucoma, certain eye diseases, or allergy to Rocklatan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study enrolls people who have cataracts and primary open-angle glaucoma that is being treated with eye drops. It will look at how well the Hydrus microstent works after approval, especially for lowering eye pressure safely.
This study tests a new eye drop medicine (DNN.31.19.026) to lower pressure inside the eye for people with glaucoma or ocular hypertension. The goal is to see if it works safely when combined with other eye pressure medications.
This trial tests a surgical system for people with mild to moderate open-angle glaucoma. It may be an option if you are having cataract surgery or have already had it, and your eye pressure is not well controlled with medications.
This study compares a new combination eye drop (Rocklatan) to a standard one (Latanoprost) to see how well they control eye pressure over 24 hours. It may help people with open-angle glaucoma or high eye pressure find a more effective treatment.
This study compares two eye drops—Rocklatan and latanoprost—for people with open-angle glaucoma who have already had a laser treatment (DSLT). It tests whether one drop works better than the other at lowering eye pressure after the laser.
This study tests how the eye drop Rocklatan (a combination of latanoprost and netarsudil) affects blood flow in the back of the eye for people with early open-angle glaucoma. If you already use latanoprost but your eye pressure is still 17 or higher, this trial may explore if adding another medicine improves optic nerve health.
Hear when a new Primary Open Angle Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.